Related Experiment Video

Updated: Aug 24, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Potential role of fluoroquinolone therapy in childhood otitis media

Ron Dagan1, Adriano Arguedas, Urs B Schaad

  • 1Pediatric Infectious Disease Unit, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel. rdagan@bgumail.bgu.ac.il

The Pediatric Infectious Disease Journal
|May 8, 2004
PubMed

Insights

Antibiotic resistance in pediatric acute otitis media is rising, limiting treatment options. Newer fluoroquinolones show promise for multidrug-resistant infections, with no clear link to childhood arthrotoxicity.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Pharmacology

Background:

  • Increasing antibiotic resistance in Streptococcus pneumoniae and other pathogens poses a significant threat to treating acute otitis media (AOM) in children.
  • Limited therapeutic choices are available for pediatric AOM cases with recurrent infections or following treatment failure.
  • Concerns regarding arthrotoxicity, a primary safety issue, have historically limited fluoroquinolone use in pediatric populations.

Purpose of the Study:

  • To evaluate the potential role of fluoroquinolones, particularly newer 8-methoxyfluoroquinolones, in managing pediatric acute otitis media.
  • To address the therapeutic gap for children with recurrent or treatment-refractory AOM.
  • To assess the safety profile of fluoroquinolones in pediatric use, specifically concerning arthrotoxicity.

Main Methods:

  • Review of existing literature on fluoroquinolone use in pediatric AOM.
  • Analysis of compassionate use data and pediatric study outcomes.
  • Examination of safety data focusing on arthrotoxicity associated with fluoroquinolone therapy.

Main Results:

  • Limited pediatric experience with fluoroquinolones has not unequivocally linked them to arthrotoxicity.
  • Emerging data suggests newer 8-methoxyfluoroquinolones may be a viable option for specific pediatric AOM cases.
  • These newer agents show potential utility in managing infections caused by multidrug-resistant pathogens.

Conclusions:

  • Fluoroquinolones, especially novel 8-methoxy derivatives, represent a potential therapeutic avenue for challenging pediatric acute otitis media cases.
  • The safety concern of arthrotoxicity in children requires careful consideration but has not been definitively established with current limited data.
  • Further research is warranted to establish the definitive role and safety of these agents in pediatric infectious disease management.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.